Kye‐Il Joo

1.5k total citations
26 papers, 1.2k citations indexed

About

Kye‐Il Joo is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Kye‐Il Joo has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Genetics and 7 papers in Immunology. Recurrent topics in Kye‐Il Joo's work include RNA Interference and Gene Delivery (14 papers), Virus-based gene therapy research (13 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Kye‐Il Joo is often cited by papers focused on RNA Interference and Gene Delivery (14 papers), Virus-based gene therapy research (13 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Kye‐Il Joo collaborates with scholars based in United States. Kye‐Il Joo's co-authors include Pin Wang, Yi Tang, Zhen Gu, Biliang Hu, Yarong Liu, Muxun Zhao, Anuradha Biswas, Xiao Liang, Jinxu Fang and Jiansong Xie and has published in prestigious journals such as Journal of the American Chemical Society, Nano Letters and ACS Nano.

In The Last Decade

Kye‐Il Joo

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kye‐Il Joo United States 16 753 370 336 225 184 26 1.2k
Catherine Yao United States 12 954 1.3× 482 1.3× 470 1.4× 136 0.6× 176 1.0× 18 1.6k
Mingnan Chen United States 13 531 0.7× 506 1.4× 297 0.9× 184 0.8× 226 1.2× 26 1.2k
Hila Epstein-Barash United States 11 1.4k 1.9× 334 0.9× 361 1.1× 166 0.7× 138 0.8× 14 2.1k
Richard Laga Czechia 18 536 0.7× 317 0.9× 280 0.8× 107 0.5× 105 0.6× 45 1.1k
Amir K. Varkouhi Netherlands 12 1.4k 1.8× 592 1.6× 498 1.5× 216 1.0× 83 0.5× 17 2.0k
Arash Hatefi United States 25 1.1k 1.5× 630 1.7× 377 1.1× 474 2.1× 238 1.3× 57 2.1k
You-Kyoung Kim South Korea 26 1.3k 1.7× 496 1.3× 351 1.0× 528 2.3× 74 0.4× 53 1.9k
Peizhuo Zhang China 18 1.0k 1.3× 355 1.0× 292 0.9× 85 0.4× 93 0.5× 32 1.4k
Joseph Hardie United States 16 773 1.0× 264 0.7× 360 1.1× 99 0.4× 82 0.4× 27 1.3k
Biliang Hu United States 17 604 0.8× 254 0.7× 385 1.1× 276 1.2× 536 2.9× 20 1.3k

Countries citing papers authored by Kye‐Il Joo

Since Specialization
Citations

This map shows the geographic impact of Kye‐Il Joo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kye‐Il Joo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kye‐Il Joo more than expected).

Fields of papers citing papers by Kye‐Il Joo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kye‐Il Joo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kye‐Il Joo. The network helps show where Kye‐Il Joo may publish in the future.

Co-authorship network of co-authors of Kye‐Il Joo

This figure shows the co-authorship network connecting the top 25 collaborators of Kye‐Il Joo. A scholar is included among the top collaborators of Kye‐Il Joo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kye‐Il Joo. Kye‐Il Joo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Jinxu, Xiao Liang, Kye‐Il Joo, et al.. (2015). A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. International Journal of Cancer. 138(4). 1013–1023. 101 indexed citations
2.
Liu, Yarong, et al.. (2014). Visualization of intracellular pathways of engineered baculovirus in mammalian cells. Virus Research. 181. 81–91. 13 indexed citations
3.
Zhao, Muxun, Yarong Liu, Wanyi Tai, et al.. (2014). Clickable Protein Nanocapsules for Targeted Delivery of Recombinant p53 Protein. Journal of the American Chemical Society. 136(43). 15319–15325. 95 indexed citations
4.
Liu, Yarong, et al.. (2013). Visualization of DC-SIGN-Mediated Entry Pathway of Engineered Lentiviral Vectors in Target Cells. PLoS ONE. 8(6). e67400–e67400. 14 indexed citations
5.
Liu, Yarong, et al.. (2013). Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation. Journal of Biomedical Materials Research Part B Applied Biomaterials. 102(5). 1101–1112. 11 indexed citations
6.
Liu, Yarong, et al.. (2012). Site‐Specific Modification of Adeno‐Associated Viruses via a Genetically Engineered Aldehyde Tag. Small. 9(3). 421–429. 46 indexed citations
7.
Liang, Xiao, et al.. (2012). Dendritic Cell-Directed Vaccination with a Lentivector Encoding PSCA for Prostate Cancer in Mice. PLoS ONE. 7(11). e48866–e48866. 20 indexed citations
8.
Froelich, Steven, et al.. (2011). Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. Journal of Biological Engineering. 5(1). 1–1. 35 indexed citations
9.
Zhao, Muxun, Anuradha Biswas, Biliang Hu, et al.. (2011). Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials. 32(22). 5223–5230. 149 indexed citations
10.
11.
Joo, Kye‐Il, et al.. (2011). Gene Editing of Human Embryonic Stem Cells via an Engineered Baculoviral Vector Carrying Zinc-finger Nucleases. Molecular Therapy. 19(5). 942–950. 33 indexed citations
12.
Gu, Zhen, Anuradha Biswas, Kye‐Il Joo, et al.. (2010). Probing protease activity by single-fluorescent-protein nanocapsules. Chemical Communications. 46(35). 6467–6467. 35 indexed citations
13.
Joo, Kye‐Il, et al.. (2010). Imaging multiple intermediates of single‐virus membrane fusion mediated by distinct fusion proteins. Microscopy Research and Technique. 73(9). 886–900. 12 indexed citations
14.
Joo, Kye‐Il, et al.. (2010). Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule. Virology Journal. 7(1). 35–35. 14 indexed citations
15.
Yang, Haiguang, et al.. (2009). Cell Type-Specific Targeting with Surface-Engineered Lentiviral Vectors Co-displaying OKT3 Antibody and Fusogenic Molecule. Pharmaceutical Research. 26(6). 1432–1445. 22 indexed citations
16.
Joo, Kye‐Il, et al.. (2009). Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors. Journal of Biological Engineering. 3(1). 8–8. 22 indexed citations
17.
Gu, Zhen, Ming Yan, Biliang Hu, et al.. (2009). Protein Nanocapsule Weaved with Enzymatically Degradable Polymeric Network. Nano Letters. 9(12). 4533–4538. 127 indexed citations
18.
Yang, Haiguang, et al.. (2008). Gamma‐retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen‐specific targeting. Biotechnology and Bioengineering. 101(2). 357–368. 8 indexed citations
19.
Yang, Lili, et al.. (2008). Targeting Lentiviral Vectors to Antigen-Specific Immunoglobulins. Human Gene Therapy. 0(ja). 3420089880–3420089880. 2 indexed citations
20.
You, Jin‐Oh, et al.. (2006). Incorporation of quantum dots on virus in polycationic solution. International Journal of Nanomedicine. 1(1). 59–64. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026